glucagon glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic Glucagon-like peptide-1: Trends in Endocrinology

It was going to be $1,600 a month

The moment after the injection also matters

Available on prescription for adults with a BMI of 30 kg/m or above, or 28 kg/m or above in the presence of weight-related risk factors

Patients are advised to tell their healthcare team and anaesthetist if they are taking these medicines, and not to stop prescribed treatment without first discussing it with their doctor

This significant weight loss not only helps improve metabolic parameters in diabetes but may also bring additional benefits to cardiovascular health

Insulin helps move glucose (sugar) out of the bloodstream and into your cells, so it can be used for energy